Literature DB >> 9550186

Demonstration of potential noninvasive ultrasound brain therapy through an intact skull.

K Hynynen1, F A Jolesz.   

Abstract

Utilization of therapeutic ultrasound in the brain has been seriously limited by the commonly accepted view that these exposures would require that a piece of the skull bone be removed to allow the ultrasound beam to propagate into the brain. In this paper, the feasibility of delivering ultrasound therapy through the intact skull was studied. Sonications were performed through a piece of human skull with focused transducers at 0.248, 0.559, 1.0 and 1.68 MHz. The skull attenuated and distorted the field; however, a sharp focal spot was created at frequencies of 1 MHz or lower. At the higher frequency, the focus was destroyed. To investigate the feasibility of compensating for the ultrasound field distortion caused by the bone, phased array experiments were performed. Two arrays with 64 elements, operating at 0.6 MHz and 1.58 MHz, were used in these experiments. The phase shifts caused by the skull were measured for each element of the arrays and then compensated for by phase-control circuitry. These phase corrections allowed a sharp focus to be generated at both frequencies. Finally, tissue destruction was induced by using pulsed sonication through a piece of human skull in a rabbit brain in vivo at the frequency of 0.559 MHz. In summary, the results showed that transcranial delivery of therapeutic ultrasound into the brain may be feasible.

Entities:  

Mesh:

Year:  1998        PMID: 9550186     DOI: 10.1016/s0301-5629(97)00269-x

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  103 in total

1.  [Focused ultrasound surgery. Basics, current status, and new trends].

Authors:  J W Jenne; G Divkovic; R Rastert; J Debus; P E Huber
Journal:  Radiologe       Date:  2003-10       Impact factor: 0.635

2.  Blood-brain barrier: real-time feedback-controlled focused ultrasound disruption by using an acoustic emissions-based controller.

Authors:  Meaghan A O'Reilly; Kullervo Hynynen
Journal:  Radiology       Date:  2012-02-13       Impact factor: 11.105

Review 3.  Ultrasound enhanced drug delivery to the brain and central nervous system.

Authors:  Meaghan A O'Reilly; Kullervo Hynynen
Journal:  Int J Hyperthermia       Date:  2012       Impact factor: 3.914

4.  The impact of standing wave effects on transcranial focused ultrasound disruption of the blood-brain barrier in a rat model.

Authors:  Meaghan A O'Reilly; Yuexi Huang; Kullervo Hynynen
Journal:  Phys Med Biol       Date:  2010-08-18       Impact factor: 3.609

5.  Comparison of analytical and numerical approaches for CT-based aberration correction in transcranial passive acoustic imaging.

Authors:  Ryan M Jones; Kullervo Hynynen
Journal:  Phys Med Biol       Date:  2015-11-25       Impact factor: 3.609

6.  Longitudinal and shear mode ultrasound propagation in human skull bone.

Authors:  P J White; G T Clement; K Hynynen
Journal:  Ultrasound Med Biol       Date:  2006-07       Impact factor: 2.998

7.  Local frequency dependence in transcranial ultrasound transmission.

Authors:  P J White; G T Clement; K Hynynen
Journal:  Phys Med Biol       Date:  2006-04-19       Impact factor: 3.609

Review 8.  Magnetic resonance-guided focused ultrasound: a new technology for clinical neurosciences.

Authors:  Ferenc A Jolesz; Nathan J McDannold
Journal:  Neurol Clin       Date:  2013-11-08       Impact factor: 3.806

9.  In vivo histotripsy brain treatment.

Authors:  Jonathan R Sukovich; Charles A Cain; Aditya S Pandey; Neeraj Chaudhary; Sandra Camelo-Piragua; Steven P Allen; Timothy L Hall; John Snell; Zhiyuan Xu; Jonathan M Cannata; Dejan Teofilovic; James A Bertolina; Neal Kassell; Zhen Xu
Journal:  J Neurosurg       Date:  2018-10-01       Impact factor: 5.115

10.  Transcranial magnetic resonance imaging- guided focused ultrasound surgery of brain tumors: initial findings in 3 patients.

Authors:  Nathan McDannold; Greg T Clement; Peter Black; Ferenc Jolesz; Kullervo Hynynen
Journal:  Neurosurgery       Date:  2010-02       Impact factor: 4.654

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.